Phase I clinical and pharmacokinetic (PK) trial of the kinesin spindle protein (KSP) inhibitor MK-0731 in patients with solid tumors
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: M. N. Stein, A. Tan, K. Taber, R. Fernandez, N. G. Agrawal, E. Vandendries, K. Hsu, A. Walker, K. Holen, G. Wilding
Institution: Rutgers Cancer Institute
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W625744139
